SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
Franziska SingerAnja IrmischNora C ToussaintLinda GrobJochen SingerThomas ThurnherrNiko BeerenwinkelMitchell P LevesqueReinhard DummerLuca QuagliataSacha I RothschildAndreas WickiChristian BeiselDaniel Johannes StekhovenPublished in: BMC medical informatics and decision making (2018)
SwissMTB enables the analysis and clinical interpretation of large numbers of potentially actionable molecular targets. Thus, our workflow paves the way towards a more frequent use of comprehensive molecular diagnostics in Swiss hospitals.